APA (7th ed.) Citation

B, V., A, R., B, B., JP, P. d. B., C, F., P, B., . . . L, D. (2026). Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL1/VLDL2 catabolism in individuals with type 2 diabetes: A randomised in vivo kinetic study. Diabetologia. https://doi.org/10.1007/s00125-026-06810-6

Chicago Style (17th ed.) Citation

B, Vergès, Rouland A, Bouillet B, Pais de Barros JP, Fourmont C, Buffier P, Jourdan T, Vergas V, and Duvillard L. "Dapagliflozin Does Not Impair LDL Catabolism and Induces a Shift Towards a Closer to Normal VLDL1/VLDL2 Catabolism in Individuals with Type 2 Diabetes: A Randomised in Vivo Kinetic Study." Diabetologia 2026. https://doi.org/10.1007/s00125-026-06810-6.

MLA (9th ed.) Citation

B, Vergès, et al. "Dapagliflozin Does Not Impair LDL Catabolism and Induces a Shift Towards a Closer to Normal VLDL1/VLDL2 Catabolism in Individuals with Type 2 Diabetes: A Randomised in Vivo Kinetic Study." Diabetologia, 2026, https://doi.org/10.1007/s00125-026-06810-6.